Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001104659-22-028760 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2022-02-25 | APRE | Coiante Scott M | SVP, CFO | F - Tax | $1.74 | -14.8K | 76.6K | -16% | -$25.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-25 | F | D | 14,817 | $1.74 | 76,649 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 32,167 restricted stock units. |